Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William F Porto

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Journal of Molecular Graphics & Modelling|November 6, 2022
In silico assessment of missense point mutations on human cathelicidin LL-37William F Porto, Sergio A Alencar
Peptides|April 13, 2013
Theoretical structural insights into the snakin/GASA familyWilliam F Porto, Octavio L Franco
Peptides|April 23, 2015
Computational analyses and prediction of guanylin deleterious SNPsWilliam F Porto, Octávio L Franco, Sérgio A Alencar
Peptides|March 4, 2014
Native and recombinant Pg-AMP1 show different antibacterial activity spectrum but similar folding behaviorWilliam F Porto, Diego O Nolasco, Octavio L Franco
Journal of Molecular Modeling|June 26, 2014
In silico identification, structural characterization, and phylogenetic analysis of MdesDEF-2: a novel defensin from the Hessian fly, Mayetiola destructorWilliam F Porto, Guilherme M Fensterseifer, Octavio L Franco
Plos One|December 15, 2012
CS-AMPPred: an updated SVM model for antimicrobial activity prediction in cysteine-stabilized peptidesWilliam F Porto, Állan S Pires, Octavio L Franco
Journal of Theoretical Biology|May 25, 2017
Antimicrobial activity predictors benchmarking analysis using shuffled and designed synthetic peptidesWilliam F Porto, Állan S Pires, Octavio L Franco
Peptides|September 18, 2012
In silico identification of novel hevein-like peptide precursorsWilliam F Porto, Valéria A Souza, Diego O Nolasco, et al.
Scientific Reports|June 1, 2017
In silico analyses of deleterious missense SNPs of human apolipoprotein E3Allan S Pires, William F Porto, Octavio L Franco, et al.
Biochimica Et Biophysica Acta. General Subjects|May 27, 2021
Structural effects driven by rare point mutations in amylin hormone, the type II diabetes-associated peptideWendy S Mendes, Octavio L Franco, Sergio A Alencar, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Journal of Molecular Graphics & Modelling|November 6, 2022
In silico assessment of missense point mutations on human cathelicidin LL-37William F Porto, Sergio A Alencar
Peptides|April 13, 2013
Theoretical structural insights into the snakin/GASA familyWilliam F Porto, Octavio L Franco
Peptides|April 23, 2015
Computational analyses and prediction of guanylin deleterious SNPsWilliam F Porto, Octávio L Franco, Sérgio A Alencar
Peptides|March 4, 2014
Native and recombinant Pg-AMP1 show different antibacterial activity spectrum but similar folding behaviorWilliam F Porto, Diego O Nolasco, Octavio L Franco
Journal of Molecular Modeling|June 26, 2014
In silico identification, structural characterization, and phylogenetic analysis of MdesDEF-2: a novel defensin from the Hessian fly, Mayetiola destructorWilliam F Porto, Guilherme M Fensterseifer, Octavio L Franco
Plos One|December 15, 2012
CS-AMPPred: an updated SVM model for antimicrobial activity prediction in cysteine-stabilized peptidesWilliam F Porto, Állan S Pires, Octavio L Franco
Journal of Theoretical Biology|May 25, 2017
Antimicrobial activity predictors benchmarking analysis using shuffled and designed synthetic peptidesWilliam F Porto, Állan S Pires, Octavio L Franco
Peptides|September 18, 2012
In silico identification of novel hevein-like peptide precursorsWilliam F Porto, Valéria A Souza, Diego O Nolasco, et al.
Scientific Reports|June 1, 2017
In silico analyses of deleterious missense SNPs of human apolipoprotein E3Allan S Pires, William F Porto, Octavio L Franco, et al.
Biochimica Et Biophysica Acta. General Subjects|May 27, 2021
Structural effects driven by rare point mutations in amylin hormone, the type II diabetes-associated peptideWendy S Mendes, Octavio L Franco, Sergio A Alencar, et al.
Pageof 5